Japan-based SORA Technology is quietly emerging as one of the most ambitious players at the intersection of artificial intelligence, climate resilience and public health in Africa. The startup has secured an additional $2.5 million in the second close of its late seed round, bringing its total funding to $7.3 million and reinforcing investor confidence in its data-driven approach to infectious disease control.
The new capital follows a $4.8 million raise announced in March 2025 and introduces three new investors Daiwa House Group Investment Limited Partnership, Central Japan Innovative Research Fund I, and UNERI Capital Fund Series I who join existing backers in supporting the company’s expansion across the continent.
Founder and CEO Yosuke Kaneko says the funding will be deployed to accelerate product development, strengthen local operations and expand SORA Technology’s team. The company’s broader ambition is to build scalable systems that can deliver measurable impact across regions where healthcare infrastructure and real-time disease surveillance remain limited.
At the core of SORA Technology’s mission is malaria, a disease that continues to affect more than 200 million people annually, with Africa accounting for the vast majority of cases and nearly 600,000 deaths each year. Despite decades of intervention, gaps in data, logistics and rapid response continue to undermine eradication efforts.
Rather than offering a single tool, SORA has developed an integrated platform that combines satellite imagery, drone-collected field data and AI-powered analytics to predict outbreaks, identify high-risk zones and guide targeted interventions. The emphasis is precision reducing wasted resources, improving response times and enabling smarter decision-making for health authorities on the ground.
That model is already moving beyond pilot stages. SORA Technology is active in more than 10 African countries, including Ghana, Sierra Leone, Benin, the Democratic Republic of the Congo, Senegal, Kenya and Mozambique. The company works closely with national and local governments, universities and research institutions, embedding its technology into existing public health systems rather than attempting to replace them.
Its collaborative approach has also attracted global partners. SORA is working with the World Health Organization in Mozambique to support sustainable infectious disease control, positioning its platform as part of broader international health strategies.
Beyond public health, the company’s drone and AI capabilities are generating commercial demand in sectors such as mining and agriculture, where clients use its technology for environmental monitoring, operational efficiency and sustainability. These parallel applications help diversify revenue while keeping the company anchored to its social impact mission.
Kaneko describes the latest round as a signal of strategic alignment, not just capital infusion. SORA Technology’s long-term goal, he says, is to achieve zero loss of life from infectious diseases by applying frontier technologies in regions where traditional systems fall short. As the company enters its next phase, the focus is on disciplined scale deeper partnerships, smarter data and a growing belief that drones and AI can become essential tools in Africa’s fight against disease and climate risk.
